752 related articles for article (PubMed ID: 25905624)
1. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
Sahbaz Y; Williams HD; Nguyen TH; Saunders J; Ford L; Charman SA; Scammells PJ; Porter CJ
Mol Pharm; 2015 Jun; 12(6):1980-91. PubMed ID: 25905624
[TBL] [Abstract][Full Text] [Related]
2. Ionic Liquid Forms of Weakly Acidic Drugs in Oral Lipid Formulations: Preparation, Characterization, in Vitro Digestion, and in Vivo Absorption Studies.
Sahbaz Y; Nguyen TH; Ford L; McEvoy CL; Williams HD; Scammells PJ; Porter CJH
Mol Pharm; 2017 Nov; 14(11):3669-3683. PubMed ID: 28954512
[TBL] [Abstract][Full Text] [Related]
3. Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo Exposure.
Tay E; Nguyen TH; Ford L; Williams HD; Benameur H; Scammells PJ; Porter CJH
Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31877828
[TBL] [Abstract][Full Text] [Related]
4. Ionic liquids provide unique opportunities for oral drug delivery: structure optimization and in vivo evidence of utility.
Williams HD; Sahbaz Y; Ford L; Nguyen TH; Scammells PJ; Porter CJ
Chem Commun (Camb); 2014 Feb; 50(14):1688-90. PubMed ID: 24394756
[TBL] [Abstract][Full Text] [Related]
5. Stabilising disproportionation of lipophilic ionic liquid salts in lipid-based formulations.
Lai A; Sahbaz Y; Ford L; Nguyen TH; Haque S; Williams HD; Benameur H; Scammells PJ; Porter CJH
Int J Pharm; 2021 Mar; 597():120292. PubMed ID: 33581479
[TBL] [Abstract][Full Text] [Related]
6. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
[TBL] [Abstract][Full Text] [Related]
7. Formulation and in vitro evaluation of self-emulsifying formulations of Cinnarizine.
Vithlani S; Sarraf S; Chaw CS
Drug Dev Ind Pharm; 2012 Oct; 38(10):1188-94. PubMed ID: 22196372
[TBL] [Abstract][Full Text] [Related]
8. The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs.
Yeap YY; Trevaskis NL; Porter CJ
Mol Pharm; 2013 Jul; 10(7):2601-15. PubMed ID: 23697606
[TBL] [Abstract][Full Text] [Related]
9. Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discovery.
Morgen M; Saxena A; Chen XQ; Miller W; Nkansah R; Goodwin A; Cape J; Haskell R; Su C; Gudmundsson O; Hageman M; Kumar A; Chowan GS; Rao A; Holenarsipur VK
Eur J Pharm Biopharm; 2017 Aug; 117():212-223. PubMed ID: 28438550
[TBL] [Abstract][Full Text] [Related]
10. Development of lipid-based SEDDS using digestion products of long-chain triglyceride for high drug solubility: Formulation and dispersion testing.
Desai HH; T M Serajuddin A
Int J Pharm; 2024 Apr; 654():123953. PubMed ID: 38417725
[TBL] [Abstract][Full Text] [Related]
11. Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations.
Williams HD; Ford L; Han S; Tangso KJ; Lim S; Shackleford DM; Vodak DT; Benameur H; Pouton CW; Scammells PJ; Porter CJH
Mol Pharm; 2018 Dec; 15(12):5678-5696. PubMed ID: 30376336
[TBL] [Abstract][Full Text] [Related]
12. Lipid-Based Formulations Can Enable the Model Poorly Water-Soluble Weakly Basic Drug Cinnarizine To Precipitate in an Amorphous-Salt Form During In Vitro Digestion.
Khan J; Rades T; Boyd BJ
Mol Pharm; 2016 Nov; 13(11):3783-3793. PubMed ID: 27631273
[TBL] [Abstract][Full Text] [Related]
13. Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations.
Chudasama A; Patel V; Nivsarkar M; Vasu K; Shishoo C
Drug Deliv; 2015; 22(4):531-40. PubMed ID: 24601856
[TBL] [Abstract][Full Text] [Related]
14. Transformation of Biopharmaceutical Classification System Class I and III Drugs Into Ionic Liquids and Lipophilic Salts for Enhanced Developability Using Lipid Formulations.
Williams HD; Ford L; Lim S; Han S; Baumann J; Sullivan H; Vodak D; Igonin A; Benameur H; Pouton CW; Scammells PJ; Porter CJH
J Pharm Sci; 2018 Jan; 107(1):203-216. PubMed ID: 28549907
[TBL] [Abstract][Full Text] [Related]
15. The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug.
Lee KW; Porter CJ; Boyd BJ
J Pharm Sci; 2013 Feb; 102(2):565-78. PubMed ID: 23242691
[TBL] [Abstract][Full Text] [Related]
16. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
[TBL] [Abstract][Full Text] [Related]
17. Spray Encapsulation as a Formulation Strategy for Drug-Based Room Temperature Ionic Liquids: Exploiting Drug-Polymer Immiscibility to Enable Processing for Solid Dosage Forms.
Stocker MW; Healy AM; Ferguson S
Mol Pharm; 2020 Sep; 17(9):3412-3424. PubMed ID: 32852215
[TBL] [Abstract][Full Text] [Related]
18. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.
Gursoy RN; Benita S
Biomed Pharmacother; 2004 Apr; 58(3):173-82. PubMed ID: 15082340
[TBL] [Abstract][Full Text] [Related]
19. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
[TBL] [Abstract][Full Text] [Related]
20. Absorption of cinnarizine from type II lipid-based formulations: Impact of lipid chain length, supersaturation, digestion, and precipitation inhibition.
Paulus F; Holm R; Stappaerts J; Bauer-Brandl A
Eur J Pharm Sci; 2024 Jun; 197():106765. PubMed ID: 38608735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
